about
Cell-penetrating peptides and their analogues as novel nanocarriers for drug deliveryAntimicrobial activity of carbon-based nanoparticlesPolymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.Comparison of the Analgesic Effect of Diclofenac Sodium-Eudragit(®) RS100 Solid Dispersion and Nanoparticles Using Formalin Test in the Rats.Drug release kinetics and physicochemical characteristics of floating drug delivery systems.Antimicrobial activity of the metals and metal oxide nanoparticles.Calcium carbonate nanoparticles as cancer drug delivery system.A sight on protein-based nanoparticles as drug/gene delivery systems.Liquisolid technology: What it can do for NSAIDs delivery?Biodegradable and biocompatible polymers for tissue engineering application: a review.Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.Physicochemical characterization and in vivo evaluation of triamcinolone acetonide-loaded hydroxyapatite nanocomposites for treatment of rheumatoid arthritis.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures.Anti Pneumococcal Activity of Azithromycin-Eudragit RS100 Nano-FormulationsDevelopment and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers.Applications of electrospinning/electrospraying in drug delivery.Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi.Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents.Inclusion of piroxicam in mesoporous phosphate glass-ceramic and evaluation of the physiochemical characteristics.Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.The effect of Beta-cyclodextrin on percutaneous absorption of commonly used Eusolex® sunscreens.Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization.Propranolol hydrochloride osmotic capsule with controlled onset of release.Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits.Morphological and physicochemical evaluation of the propranolol HCl-Eudragit® RS100 electrosprayed nanoformulations.Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.Application of Box-Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles.Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method.Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus.Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.
P50
Q26801860-95FF044F-931B-4FA7-B1BF-ED98BD85C6FBQ28389452-7B1A4E1C-69F1-4CFE-9766-310580A3E20FQ34538455-4EB0BFA1-B935-4C9E-A815-DDC1AA5DB345Q35155314-460B0114-C246-4EAB-9DA5-E57BF33D2624Q37867128-F1A4C477-07C5-4902-AED5-63116CC1011EQ38256523-35BDBD70-4D91-4F55-BB03-24288005C5F3Q38500958-109A2AEE-71B8-4E0A-A6FF-7348516377D5Q38573478-DAA8A3A6-8E48-406B-A883-808FA40E5E6BQ38591550-7A8EAEAB-84D4-4000-A5C9-F732A276CC4EQ38753834-E7C2D6D1-87E6-4A6D-8BA9-DD442B22A34DQ38770287-A7B1D746-2FDD-4A0E-8C7B-DFCFB1EDAAFDQ38803862-C18FB462-95F6-493A-9C86-38AF991453FBQ38879581-7322C389-C424-4AF5-8F35-650413923A76Q39273162-E7791D77-8D2F-4737-BF78-A4574771208EQ40494994-F6997AA1-74BB-4872-BF6B-923F6C7C3251Q41822052-2EAA326E-D54D-47F4-A575-273A61863172Q41859836-251739BA-19B5-4BE5-9C75-4A406854F211Q42024752-AF245719-4482-4152-82C3-2FE38C8E24AAQ42575422-E79B6BC7-5629-4640-8ECC-585F869CBDB2Q42933808-AC13152C-F0E8-4CA1-99B6-3DBB43EBC36BQ43014538-4ED581ED-B067-4C54-8759-7C2052861A46Q43289088-D1416162-61E5-485F-BE8E-E711138AB3C1Q44030055-53471ECB-7E9B-4C44-BDEB-9D46AEAD3986Q44276977-B5F21374-3BC9-4DB9-930B-8086EF7EBF63Q44364824-4182D8B0-88C5-4C22-B6A8-3F44F4B779FCQ44849266-02F71879-5532-4141-A807-E62D7104CD7DQ45710548-E26CEF01-9785-4F62-936D-044633E6D42BQ45753371-49EF78A0-705F-487D-AE69-BFFD5D98BD9EQ45754039-7148E95F-3D2E-4DFB-AA1A-9A3CCE56772FQ46906660-3FCFDAB9-3EB2-4EA9-88EA-702F05C997C8Q46978247-1E7DA030-AEC3-43CC-8B6E-B5863CD543A0Q48014962-78A6566E-55B4-4E7C-B211-872273B58D77Q50853205-CC8A790F-1595-4E26-BDE8-B21B074BE974Q50919035-3ABD7C25-077D-4512-AC1E-8A81F3BF1281Q51201863-A33C87F7-9303-4400-9F85-623C0BC9E106Q51228510-C3223AD3-87DC-4C06-A5E2-96F5DDEB6A5CQ51701301-8B84476E-CE84-4FAF-BAF1-3BEAEF09D9F5Q53067118-37F6F3BD-5CDD-48D4-9C3C-5B9938B2CED4Q53137843-F6021305-722C-4AAC-B5B9-3ECB9B953BC0Q53458423-51B919CB-9F92-4B33-A844-793FD0398EE5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Khosro Adibkia
@ast
Khosro Adibkia
@en
Khosro Adibkia
@es
Khosro Adibkia
@sl
type
label
Khosro Adibkia
@ast
Khosro Adibkia
@en
Khosro Adibkia
@es
Khosro Adibkia
@sl
prefLabel
Khosro Adibkia
@ast
Khosro Adibkia
@en
Khosro Adibkia
@es
Khosro Adibkia
@sl
P106
P31
P496
0000-0002-1053-5557